Delivery Order SPE2DB20D1100-SPE2DB25FE3L0
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $22,804.02 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (eight-count units). This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical product will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $33,478.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, designated...
- The U.S. Defense Department's Medical Supply Chain division awarded a $31,442.74 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this...
- The Defense Logistics Agency awarded a delivery order valued at $20,618.98 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 4, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) valued at $1,827.24. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,431.99 on August 28, 2025, for NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $16,100.02 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). The contract is classified as firm fixed price with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by August 20, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3L0Delivery Order
The Defense Logistics Agency awarded a $55,722.80 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical role as a pharmaceutical supplier within the federal medical procurement system. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. NURTEC ODT (rimegepant) is a migraine treatment medication, reflecting AmerisourceBergen's established pattern of delivering neurological and pain management pharmaceuticals to support federal medical supply needs.